Headquartered in Israel, Teva Pharmaceutical is one of the world's largest generic pharmaceutical manufacturers. The company also develops and sells branded pharmaceuticals in central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent about 55% of total revenue, with branded drug and distribution revenue making up the balance of sales. Prior to generic competition, Copaxone made up about half of Teva's branded drug segment, with about $4 billion in annual sales.
| Website: | www.tevapharm.com |
| Email: | kevin.mannix@tevapharm.com |
| Main Phone: | +972 39148171 |
| Address: | 5 Basel Street |
| Address 2: | P.O. Box 3190 |
| City / Town: | Petach Tikva |
| Country: | ISR |
| Postal Code: | 4951033 |
| Exchange: | NYE |
| CEO: | Kare Schultz |
| Employees: | 51800 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Gathering Data... Please wait Headquartered in Israel, Teva Pharmaceutical is one of the world's largest generic pharmaceutical manufacturers. The company also develops and sells branded pharmaceuticals in central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent about 55% of total revenue, with branded drug and distribution revenue making up the balance of sales. Prior to generic competition, Copaxone made up about half of Teva's branded drug segment, with about $4 billion in annual sales.
| Website: | www.tevapharm.com |
| Email: | kevin.mannix@tevapharm.com |
| Main Phone: | +972 39148171 |
| Address: | 5 Basel Street |
| Address 2: | P.O. Box 3190 |
| City / Town: | Petach Tikva |
| Country: | ISR |
| Postal Code: | 4951033 |
| Exchange: | NYE |
| CEO: | Kare Schultz |
| Employees: | 51800 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 17.93 | Change $ -0.05 | Change % -0.28 | Tick N/A |
| Bid 17.93 | Bid Size 700.00 | Ask 17.94 | Ask Size 2,700.00 |
| Open 17.99 | High 18.08 | Low 17.81 | Prev Close 17.98 |
| Last Trade | Volume 4.1 mi | 52 Wk Hi 25.96 | 52 Wk Low 14.59 |
| Market Cap 19.5 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 1,089,364,466.00 | EPS (TTM) -10.89 | PE Ratio N/A | Exchange NYSE |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 25 | 24 | 24 | 25 |
| Low Target Price Estimate | 13 | 13 | 13 | 13 |
| Mean Target Price Estimate | 18.1 | 17.43 | 17.53 | 18.35 |
| Standard Deviation | 3.24 | 3.01 | 2.81 | 3.05 |
| Date of Most Recent Estimate | 05/31/18 | 05/27/18 | 05/22/18 | 06/12/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 14 | 14 | 14 | 14 |
| Moderate Sell | 1 | 1 | 1 | 1 |
| Strong Sell | 6 | 6 | 6 | 6 |
| Mean Rec. | 3.29 | 3.29 | 3.29 | 3.29 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
